Lv6
1740 积分 2023-04-21 加入
Payload-Binding Fab Fragments Increase the Therapeutic Index of MMAE Antibody–Drug Conjugates
5小时前
待确认
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
15小时前
待确认
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice
10天前
已完结
Targeting Solid Tumors Using CD3 Bispecific Antibodies
10天前
已完结
Mechanisms Of Response And Resistance To PSMAXCD3 Bispecifics In CD34+ Humanized Mice
10天前
已完结
Data from Mechanisms of Response and Resistance to PSMA×CD3 Bispecifics in CD34<sup>+</sup> Humanized Mice
10天前
已关闭
ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers
11天前
已完结
Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment
11天前
已完结
Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer
17天前
已完结
Novel antibody-drug conjugate based on DXd-ADC technology
17天前
已完结
皖公网安备34019202002308
